Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BY-NCDrug design, development and therapy

Quadratus Lumborum versus Transversus Abdominis Plane Block with Oxycodone or Sufentanil for Recovery Quality After Laparoscopic Gastrointestinal Cancer Surgery: A Factorial Randomized Trial.

4 affiliations
  1. 1Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China.
  2. 2Institute of Anesthesiology, Soochow University, Suzhou, Jiangsu, People's Republic of China.
  3. 3Department of Anesthesiology, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, People's Republic of China.
  4. 4Department of Anesthesiology and Pain Medicine, University of California Davis Health, Sacramento, CA, USA.

Abstract

Quadratus lumborum block (QLB) theoretically provides broader visceral analgesia than transversus abdominis plane block (TAPB), while oxycodone, a dual μ- and κ-opioid receptor agonist, may offer superior visceral pain control compared with sufentanil. We evaluated these two regional techniques and two opioid regimens simultaneously in a factorial design to determine their effects on recovery after laparoscopic gastrointestinal cancer surgery. In this single-center, randomized, 2×2 factorial trial, 120 adults were randomly assigned to bilateral QLB or TAPB (0.375% ropivacaine 20 mL per side) and oxycodone or sufentanil patient-controlled analgesia. All patients received intraoperative dexmedetomidine and flurbiprofen axetil. The primary outcome was 24-h recovery quality (15-item quality of recovery scale; minimal clinically important difference 6 points). Secondary outcomes included recovery quality at 48 and 72 h, visceral and incisional pain, opioid consumption, rescue analgesia, and adverse events. For 24-h recovery quality, no significant interaction was found between block and opioid (P = 0.283); QLB vs TAPB (mean [SD] 102.1 [7.9] vs 102.6 [7.6]; mean difference -0.5, 95% CI -3.3 to 2.4; P = 0.740) and oxycodone vs sufentanil (103.7 [6.9] vs 100.9 [8.3]; mean difference 2.8, 95% CI 0.1 to 5.6; P = 0.045) did not reach the Bonferroni-corrected threshold (P < 0.025) or the 6-point difference. Oxycodone was associated with lower visceral pain scores at 1, 6, 24 and 48 h, lower incisional pain scores at 1 and 6 h, and decreased rescue analgesia use (13.3% vs 29.3%). Other outcomes were comparable. Within comprehensive multimodal analgesia, neither QLB nor oxycodone demonstrated superior recovery compared with TAPB or sufentanil. Exploratory findings of lower postoperative pain and less rescue analgesia with oxycodone should be considered hypothesis-generating. Chinese Clinical Trial Registry (ChiCTR2400080766).

Related

  1. Impacts of Oliceridine versus Sufentanil on the Quality of Postoperative Recovery in Elective Gynecological Laparoscopic Surgery: A Randomized Controlled Trial
    Chenxin Jiang, Ruonan Song, Di Wang +8
    Drug Design, Development and TherapyPeer-reviewedCC BY-NC 4.0Full textSurgery & anaesthesiaPMC
  2. Comparison of Laparoscopic-Assisted Transversus Abdominis Plane Block and Trocar-Site Local Anesthetic Infiltration After Laparoscopic Appendectomy: A Randomized Controlled Trial.
    İksan Taşdelen, Fatih Kilic, Kemal Memişoğlu +3
    CureusPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  3. Effect of video-assisted informed consent on preoperative anxiety in patients undergoing laparoscopic gastrointestinal cancer surgery: a randomized controlled trial
    Abdurrahman Başpınar, Fırat Tekeş, Ezgi Altınsoy +5
    Videosurgery and other Miniinvasive TechniquesPeer-reviewedCC BY-NC-SA 4.0Full textSurgery & anaesthesiaPMC
  4. Remimazolam versus propofol for elderly patients undergoing laparoscopic gastrointestinal surgery: a randomized trial concentrating on delirium and hemodynamic stability
    Hongna Fan, Xiaotong Chen, Linlin Xu +5
    Frontiers in medicinePeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
  5. Anterior Quadratus Lumborum Block for Postoperative Analgesia in Hip Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis
    Burhan Dost, Yunus Emre Karapinar, Esra Turunc +4
    Balkan Medical JournalPeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaPMCDOAJ
BibTeX
@article{yang2026quadratus,
  title = {{Quadratus Lumborum versus Transversus Abdominis Plane Block with Oxycodone or Sufentanil for Recovery Quality After Laparoscopic Gastrointestinal Cancer Surgery: A Factorial Randomized Trial.}},
  author = {Guo-Wang Yang and Xiao-Yang Song and Yu-Fan Yang and Hong Liu and Fu-Hai Ji and Ke Peng},
  journal = {Drug design, development and therapy},
  year = {2026},
  month = oct,
  doi = {10.2147/dddt.s641249},
  url = {https://europepmc.org/article/MED/42953751},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Quadratus Lumborum versus Transversus Abdominis Plane Block with Oxycodone or Sufentanil for Recovery Quality After Laparoscopic Gastrointestinal Cancer Surgery: A Factorial Randomized Trial.
AU  - Guo-Wang Yang
AU  - Xiao-Yang Song
AU  - Yu-Fan Yang
AU  - Hong Liu
AU  - Fu-Hai Ji
AU  - Ke Peng
PY  - 2026
DA  - 2026/10/24
JO  - Drug design, development and therapy
DO  - 10.2147/dddt.s641249
UR  - https://europepmc.org/article/MED/42953751
AB  - Quadratus lumborum block (QLB) theoretically provides broader visceral analgesia than transversus abdominis plane block (TAPB), while oxycodone, a dual μ- and κ-opioid receptor agonist, may offer superior visceral pain control compared with sufentanil. We evaluated these two regional techniques and two opioid regimens simultaneously in a factorial design to determine their effects on recovery after laparoscopic gastrointestinal cancer surgery. In this single-center, randomized, 2×2 factorial trial, 120 adults were randomly assigned to bilateral QLB or TAPB (0.375% ropivacaine 20 mL per side) and oxycodone or sufentanil patient-controlled analgesia. All patients received intraoperative dexmedetomidine and flurbiprofen axetil. The primary outcome was 24-h recovery quality (15-item quality of recovery scale; minimal clinically important difference 6 points). Secondary outcomes included recovery quality at 48 and 72 h, visceral and incisional pain, opioid consumption, rescue analgesia, and adverse events. For 24-h recovery quality, no significant interaction was found between block and opioid (P = 0.283); QLB vs TAPB (mean [SD] 102.1 [7.9] vs 102.6 [7.6]; mean difference -0.5, 95% CI -3.3 to 2.4; P = 0.740) and oxycodone vs sufentanil (103.7 [6.9] vs 100.9 [8.3]; mean difference 2.8, 95% CI 0.1 to 5.6; P = 0.045) did not reach the Bonferroni-corrected threshold (P < 0.025) or the 6-point difference. Oxycodone was associated with lower visceral pain scores at 1, 6, 24 and 48 h, lower incisional pain scores at 1 and 6 h, and decreased rescue analgesia use (13.3% vs 29.3%). Other outcomes were comparable. Within comprehensive multimodal analgesia, neither QLB nor oxycodone demonstrated superior recovery compared with TAPB or sufentanil. Exploratory findings of lower postoperative pain and less rescue analgesia with oxycodone should be considered hypothesis-generating. Chinese Clinical Trial Registry (ChiCTR2400080766).
SN  - 1177-8881
ER  -